Related Experiment Videos

Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation

M Zohar1, H Teramoto, B Z Katz

  • 1Oral and Pharyngeal Cancer Branch, National Institute of Dental Research, Bethesda, Maryland 20892-4330, USA.

Oncogene
|September 25, 1998
PubMed

Insights

Rho proteins regulate cell functions, but their oncogenic potential isn't solely due to cytoskeletal changes. Specific mutations disrupt gene transcription and transformation, separating these cellular effects.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Rho proteins are small GTP-binding proteins crucial for actin cytoskeleton organization, gene expression, and cellular transformation.
  • Ras proteins, distinct from Rho, potently transform cells without inducing actin stress fibers.

Purpose of the Study:

  • To investigate if Rho's nuclear signaling and oncogenic potential stem from its effects on cytoskeletal organization.
  • To differentiate the molecular mechanisms underlying Rho-mediated cytoskeletal changes versus transformation.

Main Methods:

  • Mutagenesis of the Rho effector loop by replacing amino acids with those from Ras or other variants.
  • Analysis of Rho mutant signaling pathways, including MAPK, JNK, and p38.
  • Assessment of actin stress fiber formation, gene transcription via serum response factor (SRF), and neoplastic transformation.

Main Results:

  • Rho effector loop mutants retained the ability to induce actin stress fiber formation.
  • Mutants with substitutions at leucine-39, glutamic acid-39, or cysteine-42 lost the capacity to stimulate SRF-mediated gene transcription.
  • These specific Rho mutants also failed to induce neoplastic transformation, despite maintaining cytoskeletal effects.

Conclusions:

  • Cytoskeletal organization changes induced by Rho are insufficient for neoplastic transformation.
  • Rho-effector molecules responsible for actin cytostructure regulation are distinct from those mediating nuclear signaling and growth control subversion.
  • This suggests a divergence in Rho signaling pathways controlling cellular morphology and oncogenic potential.

Related Concept Videos